Microcrystalline Cellulose - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the microcrystalline cellulose market size was valued at USD 1.35 billion in 2025 and estimated to grow from USD 1.43 billion in 2026 to reach USD 1.94 billion by 2031, at a CAGR of 6.23% during the forecast period (2026-2031).

This report is Segmented by Source (Wood-Based and Non-Wood-Based), Process (Reactive Extrusion, Enzyme Mediated, Steam Explosion, and Acid Hydrolysis), End-User Industry (Pharmaceutical, Food, Cosmetics, and Other End-User Industries), and Geography (Asia-Pacific, North America, Europe, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Microcrystalline Cellulose Market Trends and Insights

Surging Pharmaceutical Tablet Manufacturing in Emerging Markets

Pharmaceutical manufacturing migration to cost-advantaged regions accelerates MCC demand as generic drug production scales exponentially in India, China, and Southeast Asia. Sigachi Industries exemplifies this trend, operating three manufacturing plants at over 95% capacity utilization while expanding capacity by 50% to meet export demand that comprises 75% of sales. Intensifying generic-drug output in India, China, and Southeast Asia propels the microcrystalline cellulose market as producers move toward direct-compression tablets that avoid wet granulation steps. Sigachi Industries' three Indian plants now run above 95% utilisation, with capacity expansion of 50% underpinning 32.1% FY24 revenue growth. Global regulatory harmonisation by World Health Organization (WHO) and Food and Drug Administration (FDA) strengthens demand for premium Microcrystalline Cellulose (MCC) grades, cementing the ingredient's role as a low-risk excipient amid supply-chain relocation to cost-advantaged regions.

Clean-label Low-fat Food Demand

Consumer health consciousness drives food manufacturers toward MCC as a multifunctional ingredient that enables fat reduction without compromising texture or mouthfeel, supporting growth in the microcrystalline cellulose market. Research demonstrates MCC's superior performance as a fat replacer in reduced-calorie formulations, with studies showing 25% fat replacement in shortcrust biscuits maintaining sensory acceptability while enhancing fiber content. The clean-label movement benefits MCC due to its simple nomenclature and natural wood pulp origin, contrasting favorably with synthetic alternatives facing consumer resistance. European Food Safety Authority (EFSA)'s re-evaluation confirming MCC safety across all food applications, with no numerical acceptable daily intake required, strengthens regulatory confidence for expanded food use. Roquette's MICROCEL product line targeting bakery, snacks, and plant-based meat applications illustrates industry commitment to food-grade MCC development. The intersection of obesity concerns and clean-label preferences creates sustained demand growth as food companies reformulate products to meet evolving consumer expectations.

High Energy-intensive Manufacturing Cost

MCC production's inherent energy intensity creates margin pressure as electricity costs escalate globally and manufacturers confront sustainability reporting requirements. According to techno-economic analyses, acid hydrolysis processes require substantial steam generation and temperature maintenance, with energy representing 15-20% of total production costs. Rising natural gas prices particularly impact European producers, where energy costs exceeded historical averages throughout 2024, forcing operational adjustments and pricing strategies. Manufacturers in microcrystalline cellulose market increasingly evaluate renewable energy integration and process optimization to maintain competitiveness as carbon pricing mechanisms expand globally. The energy intensity constraint particularly affects smaller producers lacking scale economies to invest in efficient technologies, potentially accelerating industry consolidation toward larger, more efficient operations.

Other drivers and restraints analyzed in the detailed report include:

1. Cosmetics Shift to Natural Rheology Modifiers
2. Adoption of Agro-residue Feedstocks (Rice Straw, Bamboo)
3. Substitutes - CMC and Modified Starch

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Wood-derived feedstock retained 57.22% revenue in 2025 thanks to validated performance and existing qualification dossiers among pharmaceutical customers in the microcrystalline cellulose market. Nonetheless, non-wood alternatives are widening at a 7.02% CAGR as circular-economy legislation favours low-carbon agro-residues with resilient local supply chains. Rice-straw and bamboo extraction technologies reaching >=92% cellulose yield demonstrate feasibility, underpinning regional mill projects in China and India.

Intensified forestry-management scrutiny in Europe and North America accelerates diversification; in the microcrystalline cellulose market processors utilising cotton-textile waste further embed waste-valorisation credentials while reducing exposure to pulp-price volatility.

Geography Analysis

Asia-Pacific accounted for 37.18% of global revenue in 2025 and is growing fastest at 6.85% CAGR through 2031in the microcrystalline cellulose market size. China's vertically integrated pharmaceutical ecosystem, India's excipient export focus, and plentiful agricultural residues underpin the region's dominance. Japanese and South Korean suppliers contribute high-purity grades, elevating regional quality benchmarks.

North America continues to drive innovation in processing technology and advanced drug-delivery formats, though growth moderates as mature demand equilibrates. The United States benefits from FDA oversight that favours established MCC suppliers with extensive Drug Master File (DMF) dossiers. Europe's sustainability legislation and European Food Safety Authority (EFSA)'s unconditional safety opinion reinforce demand in both food and cosmetics, positioning the bloc as a regulatory bellwether.

Latin America, the Middle East, and Africa collectively remain nascent but strategically important. Brazil pairs rising pharmaceutical capacity with abundant agro-residues, suggesting future non-wood expansion. Saudi Arabia's Vision 2030 pharma build-out and South Africa's generics initiatives represent early-stage beachheads for regional supply chains.

List of Companies Covered in this Report:

1. Accent Microcell Ltd
2. Asahi Kasei Corporation
3. Avantor, Inc.
4. Blanver Farmoquimica
5. Borregaard AS
6. Chemfield Cellulose
7. DFE Pharma
8. FMC Corporation
9. Gujarat Microwax Pvt Ltd
10. Huzhou Xinwang Chemical Co.
11. J. Rettenmaier & Sohne GmbH + Co KG
12. Juku Orchem Pvt Ltd
13. Mingtai Chemical Co. Ltd.
14. Nordic Bioproducts Group
15. Roquette Freres
16. Sigachi Industries

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support